Medicamen Biotech Limited Strategic Asset Allocation Index
Medicamen Biotech Limited strategic asset allocation index. Medicamen Biotech Limited (MEDICAMEQ) has a Strategic Asset Allocation Index of 47.4% as of March 2023. Strategic assets (PP&E of Rs917.59 Million plus long-term investments of Rs-) total Rs917.59 Million, measured against net assets of Rs1.93 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Medicamen Biotech Limited balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Medicamen Biotech Limited (2018–2023)
Strategic asset allocation index of Medicamen Biotech Limited from 2018 to 2023. This chart shows how Medicamen Biotech Limited's Strategic Asset Allocation Index has evolved across 6 annual periods from 2018 to 2023. As of March 2023, the index stands at 47.4%, representing strategic assets of Rs917.59 Million against net assets of Rs1.93 Billion INR. Check Medicamen Biotech Limited (MEDICAMEQ) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Medicamen Biotech Limited Strategic Asset Allocation Index by Year (2018–2023)
Medicamen Biotech Limited strategic asset allocation index by year from 2018 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for Medicamen Biotech Limited from 2018 to 2023, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Medicamen Biotech Limited market cap and net worth.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 47.4% | Rs917.59 Million | Rs917.59 Million | Rs- | Rs1.93 Billion | ▼ -15.5 pp |
| 2022 | 62.9% | Rs921.17 Million | Rs921.17 Million | Rs- | Rs1.46 Billion | ▼ -4.4 pp |
| 2021 | 67.3% | Rs894.35 Million | Rs894.35 Million | Rs- | Rs1.33 Billion | ▲ +6.3 pp |
| 2020 | 61.0% | Rs739.21 Million | Rs739.21 Million | Rs- | Rs1.21 Billion | ▲ +16.2 pp |
| 2019 | 44.8% | Rs388.05 Million | Rs388.05 Million | Rs- | Rs866.34 Million | ▲ +10.9 pp |
| 2018 | 33.9% | Rs252.97 Million | Rs252.97 Million | Rs- | Rs746.08 Million | — |